Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Back to The Tape

Market Watch

11 Jun 2026, 18:30 UTC · 4h ago

There's a ticking time bomb under the Paramount-Warner Bros. deal. Here's what could set it off.

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

ShareX LinkedIn

There's a ticking time bomb under the Paramount-Warner Bros. deal. Here's what could set it off.

What the story claims

2 claims · each scored for market impact

What matters in this story

1
Paramount could face additional costs if regulators slow down the Skydance merger. — Increased deal costs and regulatory delays erode the net value of the merger and increase execution risk.
-0.40
2
The Paramount Skydance and Warner Bros. Discovery merger is facing resistance from Hollywood industry figures. — Industry opposition can signal potential integration friction or political hurdles, though it is less financially material than regulatory costs.
-0.20

Which stocks this story touches

How each ticker is affected

PARA-0.40
The company faces potential additional costs and regulatory hurdles regarding its merger.

6 related stories

Reuters
1h ago
Novartis says rare muscle disease drug shows promise in early trial
- m and a
Read

There's a ticking time bo… — PARA -0.40 | NewsImpactScreener

There's a ticking time bomb under the Paramount-Warner Bros. deal. Here's what could set it off.

What matters in this story

How each ticker is affected

Novartis says rare muscle disease drug shows promise in early trial

There's a ticking time bomb under the Paramount-Warner Bros. deal. Here's what could set it off.

What matters in this story

How each ticker is affected

Novartis says rare muscle disease drug shows promise in early trial

Connected tickers

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

TMX Group Limited Announces Agreement to Acquire RAFI Indices from Research Affiliates

Sportradar Securities Fraud Class Action Result of Compliance Misrepresentations and 22% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

VIA Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Via Transportation, Inc.

Friedman Industries, Incorporated Announces Fourth Quarter and Fiscal Year 2026 Results

South Korea Hits Coupang With Record Fine For Massive Data Breach

There's a ticking time bomb under the Paramount-Warner Bros. deal. Here's what could set it off.

What matters in this story

How each ticker is affected

Next reads from the same story arc

Novartis says rare muscle disease drug shows promise in early trial

There's a ticking time bomb under the Paramount-Warner Bros. deal. Here's what could set it off.

What matters in this story

How each ticker is affected

Next reads from the same story arc

Novartis says rare muscle disease drug shows promise in early trial

Connected tickers

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

TMX Group Limited Announces Agreement to Acquire RAFI Indices from Research Affiliates

Sportradar Securities Fraud Class Action Result of Compliance Misrepresentations and 22% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

VIA Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Via Transportation, Inc.

Friedman Industries, Incorporated Announces Fourth Quarter and Fiscal Year 2026 Results

South Korea Hits Coupang With Record Fine For Massive Data Breach